Lax-A-Day

Quick links to important sections

Lax-A-Day

Method of action: Laxative

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lax-A-Day

Property Description
Active Ingredient Macrogol 3350 (Polyethylene Glycol 3350)
Form Powder for oral solution
Pharmacological Class Osmotic laxative
General Purpose To soften stool and restore bowel regularity
Origin Synthetic polymer

What Type of Medicine is Lax-A-Day?

Lax-A-Day is classified as an osmotic laxative, a type of synthetic medicinal entity primarily used to address difficulties in passing stool. The medicine's active ingredient is Macrogol 3350, also known as Polyethylene Glycol 3350 (PEG 3350). Macrogol 3350 is a high molecular weight compound that is not significantly absorbed into the body, remaining primarily within the gastrointestinal tract. This means the product works locally in the gut rather than affecting other bodily systems.

Unlike stimulant laxatives, which actively prompt muscle contractions in the bowel, Lax-A-Day is designated as a non-stimulant agent. This approach is designed to provide gentle relief without causing sudden urgency. Macrogol acts to address occasional difficulty in passing stool by increasing stool frequency and consistency. This highlights its gentle, physical mode of operation to restore comfortable bowel function, especially in adult patient groups.


Composition and Physical Form

Lax-A-Day is manufactured as an unflavored powder for oral solution and is intended for the oral route of administration after being fully dissolved in a liquid. The medication is a single-ingredient product, which is a distinctive feature, relying entirely on the osmotic properties of Macrogol 3350 without added electrolytes or flavorings.

This compound, being a synthetic polymer, functions by drawing water from the body into the colon, a mechanism referred to as osmotic action. The powder is designed to dissolve completely into beverages like water or juice without altering their taste or texture, offering user convenience. By ensuring the fecal matter is adequately saturated, Macrogol 3350 creates a softer, bulkier stool mass. This increased volume and improved consistency helps the body pass stool more comfortably and consistently, supporting the overall goal of normalizing digestive rhythm. This fundamental, non-systemic approach is the core benefit delivered by this type of medicine.

Regulatory References

  1. NIH: Polyethylene Glycol 3350

What side effects are possible with Lax-A-Day?

Possible Side Effects and Safety Information

Lax-A-Day (Macrogol 3350) has a documented safety profile that is primarily focused on the gastrointestinal tract, consistent with its non-systemic, localized mechanism of action. Officially documented adverse reactions are classified by frequency and the body system affected, as established by government health authorities.

Regulatory Classification of Adverse Reactions

Classification Examples of Reactions
Very Common Abdominal pain, borborygmi (stomach rumbling).
Common Diarrhoea, vomiting, nausea, anal discomfort.
Uncommon Abdominal distension (bloating), flatulence, certain hypersensitivity reactions, dehydration, electrolyte disorders.
Rare Anaphylaxis.

Adverse events are primarily grouped under Gastrointestinal disorders. Immune system disorders (such as anaphylaxis and angioedema) and Metabolism and nutrition disorders (including electrolyte imbalances) represent the key safety concerns beyond localized intestinal effects.

Serious Safety and Contextual Patterns

Serious adverse events include severe hypersensitivity reactions and significant fluid or electrolyte disturbances that can arise from excessive diarrhoea. Diarrhoea or loose stools normally respond to a reduction in the amount of medicine used. Gastrointestinal reactions are more often observed during the treatment for faecal impaction, which is a high-dose regimen.

Population-Specific Notes: Safety documentation includes specific notes for certain groups. Older adults may experience a higher incidence of diarrhoea. Patients with underlying renal impairment are noted to be at a higher risk of water-electrolyte balance disorders if diarrhoea occurs.

Safety Restrictions: The medicine is strictly contraindicated in cases of known or suspected intestinal obstruction (ileus), intestinal perforation, toxic megacolon, or other severe inflammatory bowel conditions.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Macrogol 3350 overdose focuses strictly on the consequences of its exaggerated osmotic action.

Overdose scope (Official Regulatory Information)
Documented Manifestations Diarrhea, excessive stool frequency, and thirst.
Serious Outcomes Dehydration, which may lead to confusion, potential for seizure, and in severe cases, metabolic acidosis.
Population Notes Elderly nursing home patients may be at increased risk of excessive stool frequency at high doses.

Immediate Actions and Management

In the event of overdose, official guidance mandates to contact a Poison Control Center or seek medical help right away. Immediate emergency services must be called if the affected person has collapsed, experienced a seizure, has trouble breathing, or can't be awakened. There is no specific antidote known. Management is defined as symptomatic and supportive treatment, with the procedural focus being the correction of fluid and electrolyte abnormalities and subsequent monitoring for imbalances.

Connection to the overall overdose profile

The regulatory documents define the overdose profile by detailing the expected gastrointestinal manifestations and the subsequent risk of systemic complications, primarily fluid and electrolyte imbalance. This profile dictates that urgent medical attention is required for systemic signs of severity, such as seizures or collapse.

Therapeutic Uses of Lax-A-Day

What Lax-A-Day Treats: Main Uses and Benefits

Lax-A-Day is an osmotic laxative used primarily for the treatment of occasional constipation. Its active ingredient, Polyethylene Glycol 3350 (PEG 3350), works by retaining water in the digestive tract, which softens the stool and increases the frequency of bowel movements.

Relieving Occasional Constipation

The primary use of Lax-A-Day is to manage infrequent or difficult bowel movements. By drawing water into the colon rather than being absorbed into the bloodstream, the medication helps to facilitate a more natural transit through the digestive system. This process helps to alleviate common symptoms associated with constipation, such as:

  • Hard or dry stools
  • Straining during bowel movements
  • A sense of incomplete evacuation

Mechanism of Action and Benefits

As an osmotic agent, Lax-A-Day does not rely on stimulating the nerves of the colon or irritating the intestinal lining. This characteristic offers several benefits for patients seeking relief from irregularity:

  • Predictable Softening: The increase in water content within the stool helps to improve its consistency, making it easier to pass.
  • Non-Stimulant Approach: Because it does not force intestinal contractions, it is often utilized by those who prefer a gentler method of action compared to stimulant laxatives.
  • Metabolic Inertia: The active ingredient is not absorbed by the body in significant amounts and is excreted unchanged, focusing its effect entirely within the gastrointestinal tract.

Support for Digestive Regularity

Beyond immediate relief, Lax-A-Day is used to help restore a more consistent digestive rhythm. By increasing the frequency of bowel movements to a normal range, it assists in stabilizing the digestive process for individuals experiencing temporary disruptions due to diet, lifestyle changes, or other non-chronic factors.

Regulatory References

  1. Polyethylene Glycol 3350: MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility profile for Lax-A-Day (Macrogol 3350) is strictly defined by regulatory authorities based on patient age and specific medical conditions. The medicine is intended for use by adults and adolescents 17 years of age and older.

Official Eligibility Constraints

Population Status Regulatory Rule
Contraindicated Use is strictly prohibited for patients with intestinal obstruction (ileus), gastrointestinal perforation, toxic colitis, toxic megacolon, or a confirmed allergy to polyethylene glycol (PEG).
Conditional Use Use is restricted and requires the supervision of a physician for individuals with kidney disease (renal impairment), Irritable Bowel Syndrome (IBS), or unexplained acute symptoms like nausea, vomiting, or abdominal pain.
Pediatric Use The safety and effectiveness of the adult product in children 16 years of age and under is not established. Use in this age group must be determined by a doctor.
Pregnancy/Lactation The medicine may be used during both pregnancy and breastfeeding. No systemic effects on the fetus or infant are anticipated due to the negligible absorption of the active ingredient.

The eligibility rules are grounded in patient safety and the physiological mechanism of osmotic laxatives, ensuring the medicine is not administered when the integrity of the gastrointestinal system is compromised.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Lax-A-Day (Macrogol 3350), which primarily involve physical or absorption interference. As the medicine is non-systemic, its regulatory profile does not include interactions based on metabolic enzymes or drug transporters.


Documented Interactions

Interacting Substance Interaction Classification Official Outcome
Other Oral Medicinal Products Transient Absorption Interference Co-administration may result in transiently reduced absorption of the co-administered drug. Decreased efficacy has been specifically reported in isolated cases involving oral anti-epileptics.
Starch-based Food Thickeners Physical Substance Counteraction Co-administration causes a physical interaction that counteracts the thickening property, leading to liquefaction of the prepared thickener.

Regulatory Constraints

The documented risk of transiently reduced absorption for other oral medicines implies a necessary consideration for timing separation of administration to ensure the therapeutic efficacy of co-administered drugs. The product's physical interaction with starch-based food thickeners means this combination should generally be avoided, as stated in official labeling. No drug-drug combinations are formally classified as contraindicated based on regulatory documents.

Mechanism of Action

The following content adheres strictly to the mechanistic requirements:

How Lax-A-Day Works

Lax-A-Day (Polyethylene Glycol 3350) operates through a distinct physicochemical mechanism entirely confined to the gastrointestinal tract, targeting the dynamics of water within the colon.

Primary Mechanism: Osmotic Action and Water Dynamics

This domain covers the function of the compound: how it leverages an osmotic gradient to draw and retain water. As a non-absorbable, inert molecule, Lax-A-Day remains in the bowel lumen, creating a high solute concentration that forces water from the surrounding tissues into the stool mass, fundamentally altering its composition.


Resulting Physiological Effect: Stool Softening and Bulk

This mechanism directly leads to the consequence of stool softening. The water retention significantly increases the stool's liquid content and volume, contributing to a bulk that is easier to transit and supports the resultant increased motility of the mass.


Mechanistic Domain: Non-Systemic Inertia

The mechanism is defined by the drug's lack of interaction with specific cellular receptors or neural pathways. Its activity is wholly confined to the gastrointestinal lumen, resulting in no detectable systemic biological activity.

Dosage and Administration Information

Lax-A-Day, which contains the active ingredient Polyethylene Glycol 3350 (PEG 3350), is an osmotic laxative used to relieve occasional constipation. It works by increasing the water content in the stool, softening it and making passage easier.

Recommended Dosing and Preparation

Patient Group Single Dose Frequency Duration of Use
Adults (17 years and older) 17 grams (g) Once daily No more than 7 days*

*Use for longer than seven days should only be done under the direction of a healthcare professional.

To prepare the dose:

  1. Measure 17 grams of the powder, typically using the measuring cap supplied with the product, filled to the indicated line.
  2. Pour the measured powder into a cup containing 120 mL to 240 mL (4 to 8 ounces) of any non-alcoholic beverage. Suitable liquids include water, juice, soda, coffee, or tea.
  3. Stir the mixture thoroughly until the powder is fully dissolved. The solution should be consumed immediately.

Important Considerations

Lax-A-Day generally produces a bowel movement within one to three days of starting treatment. Do not exceed the recommended daily dosage, as this may lead to severe diarrhea and potential dehydration. If symptoms of constipation worsen, or if you experience severe abdominal pain, nausea, or rectal bleeding, discontinue use and consult a physician.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lax-A-Day (Macrogol 3350)

Evidence for Use in Chronic Constipation

Research has explored how symptoms change over time in individuals experiencing chronic constipation, a condition characterized by functional limitations. The evidence base includes numerous Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies were designed to monitor patterns related to physical discomfort and functional imbalance.

Research examined key outcomes such as the weekly frequency of bowel movements and measurements of stool consistency. Findings describe patterns observed in the studies, including measurements of bowel movement frequency relative to placebo groups. Studies report how symptoms evolved in the observed populations during these trials, contributing to the broader evidence landscape.

While the research provides context, findings describe group patterns, not personal outcomes. This means research does not determine whether an individual will respond similarly. Furthermore, comparative evidence between different Macrogol formulations can be mixed, and certainty remains low regarding some specific aspects of long-term use.

Evidence for Management of Severe Stool Retention (Faecal Impaction)

Macrogol 3350 was studied for its use in addressing acute, severe stool retention, which is a condition associated with acute or disruptive episodes. This research explored short-term symptom changes, particularly within the pediatric population. The primary outcome measured was the documentation of the resolution of the impaction over defined time intervals.

Reports from these studies monitored how symptoms evolved in the observed populations. Findings indicate that Macrogol 3350 was associated with patterns of impaction resolution that were observed in studies comparing it to other established methods. These results reflect the specific, very short-term conditions under which the research was conducted.

What Remains Uncertain in the Research Landscape

Key research limitation frames include that long-term effects are not fully established because follow-up durations were limited in the most rigorous trials. Additionally, the existing research provides limited data comparing certain specific Macrogol formulations. Results apply only to the populations studied, and the evidence quality varies across studies. Data for certain comorbidity groups remain limited, and results varied regarding some specific comparisons. These uncertainties indicate that research is ongoing to contextualize the full range of symptom patterns.

Key Studies & References

  1. Polyethylene Glycol 3350: MedlinePlus Drug Information
  2. Use of polyethylene glycol in functional constipation and fecal impaction: a review

Frequently Asked Questions (FAQ)

Common questions about Lax-A-Day (FAQ)


Q: Is Lax-A-Day the same as other polyethylene glycol products?

A: Lax-A-Day’s active ingredient is Polyethylene Glycol 3350 (PEG 3350). According to official labeling, this is the same specific chemical compound found in various other osmotic laxative products. The difference usually lies in the brand name and regional labeling.


Q: Is Lax-A-Day safe to use for a long period of time?

A: Regulatory documents limit the recommended self-treatment period to seven days or less. Official warnings advise that prolonged or excessive use beyond this period may be associated with risks of electrolyte imbalance and the development of laxative dependence. Use for longer than one week is generally not recommended unless under the guidance of a health professional.


Q: Does Lax-A-Day have a taste or texture when dissolved?

A: According to the official product information, once the powder is completely dissolved in the recommended amount of liquid, it is described as being taste-free and grit-free. Product instructions state that the solution is typically consumed immediately after preparation.


Q: Can Lax-A-Day interact with commonly used over-the-counter pain relievers?

A: As an oral medicine, Lax-A-Day’s presence in the digestive tract may lead to a transiently reduced absorption of other oral medicinal products. Regulatory constraints suggest considering time-separation of administration to help ensure the therapeutic efficacy of co-administered oral medicines.


Q: Can older adults use Lax-A-Day safely?

A: Official safety documentation notes that older adults may experience a higher incidence of diarrhoea while using this medicine. Because of this, regulatory safety notes mention the importance of monitoring for signs of dehydration, as this population may be at higher risk for related water-electrolyte balance disorders.


Q: Does Lax-A-Day require increased water intake to work properly?

A: While the powder is mixed with a beverage, official product warnings emphasize the need to maintain adequate fluid intake while using this medicine. Maintaining adequate fluid intake is noted as important for supporting its osmotic mechanism, as the drug works by drawing water into the stool.


Q: Can Lax-A-Day be taken for general daily digestive health?

A: The product is officially indicated for the relief of occasional constipation. It is not authorized or indicated in regulatory documents for use as a long-term daily supplement for general digestive or overall gut health.


Q: What is the difference between Lax-A-Day and common fiber supplements?

A: Lax-A-Day is classified as an osmotic laxative, meaning it works by drawing water into the stool to soften it. This is a different mechanism from bulk-forming fiber supplements, which typically work by increasing the volume or bulk of the stool mass.


Q: Is it possible to become dependent on Lax-A-Day for bowel movements?

A: Official product information advises against prolonged use, noting that extended, frequent, or excessive use may be associated with the development of laxative dependence. For this reason, regulatory agencies limit the self-treatment period to seven days.


Q: Are there any common foods or drinks that should be avoided while using Lax-A-Day?

A: The medicine should not be combined with starch-based food thickeners, as official sources state this interaction can counteract the thickening property and lead to liquefaction. The preparation instructions specify mixing the medicine only with non-alcoholic beverages.


Q: Can Lax-A-Day cause weight changes?

A: Systemic body weight change is not listed as a known adverse reaction in official documents. However, clinical studies track the success of the medicine by measuring expected increases in stool volume or weight that result from the drug's osmotic action.


Q: Why does the powder need to be mixed in a drink?

A: The medicine is required to be fully dissolved in liquid prior to consumption. This ensures the powder is in the appropriate dissolved form to leverage its osmotic mechanism effectively within the digestive tract.


Q: Are there different strengths or versions of Lax-A-Day available?

A: The product is based on the active ingredient Polyethylene Glycol 3350. The standard recommended dose for self-treatment in adults is uniformly set at 17 grams of the powder, which is the only strength typically offered for this use.


Q: Is Lax-A-Day safe for people with diabetes?

A: The product information generally describes the powder as being sugar-free. Official product information notes that individuals with pre-existing conditions, such as diabetes, should have a discussion with a health professional before use.


Q: Can Lax-A-Day be mixed with hot beverages?

A: Yes, the product’s preparation instructions state that the powder can be dissolved in any 4 to 8 ounces of beverage, which includes the use of hot or cold liquids such as coffee or tea.


Q: Is Lax-A-Day suitable for use in children?

A: The product's non-prescription use is typically authorized for adults and children 17 years of age and older. Use in children 16 years of age or younger is generally done only under the advice and direction of a physician.


Q: Can Lax-A-Day be taken with acid reflux medication?

A: As an oral medicine, it may cause a transiently reduced absorption of co-administered oral medicines, which includes acid reflux medication. Regulatory constraints suggest considering time-separation of administration to help ensure the therapeutic efficacy of co-administered oral medicines.


Q: Does Lax-A-Day have a generic version available?

A: Yes, the product’s active ingredient is Polyethylene Glycol 3350, which is the generic name for this compound. This ingredient is widely available under multiple brand and generic labels.


Q: Is Lax-A-Day gluten-free or suitable for people with Celiac disease?

A: Product information explicitly describes the powder as being gluten-free. This means it does not contain the common proteins found in wheat, barley, and rye.


Q: Does the time of day I take Lax-A-Day matter?

A: The medicine is intended to be taken once daily, and regulatory information does not specify a critical time of day for consumption. The onset of effect typically takes one to three days, meaning it works over a longer time span.


Q: Can Lax-A-Day be used to help prepare for medical procedures?

A: The product is officially indicated for the relief of occasional constipation. Other specialized formulations of polyethylene glycol, which contain additional electrolytes, are specifically indicated and used for bowel preparation under medical supervision.


Q: Do official documents mention specific quality-of-life improvements linked to Lax-A-Day use?

A: Clinical research focuses on measurable, functional outcomes such as bowel movement frequency and stool consistency measurements. Patient-reported quality-of-life improvements are not typically the primary focus of the clinical evidence that is summarized in regulatory documents.


Q: What kind of studies support the use of Lax-A-Day?

A: The evidence supporting the use of this medicine is grounded in numerous clinical studies, including Randomized Controlled Trials (RCTs) and Systematic Reviews. These trials are designed to measure functional outcomes related to constipation symptoms.


Q: Does Lax-A-Day interact with oral contraceptives?

A: The medicine's osmotic action in the digestive tract may lead to a transiently reduced absorption of other oral medicinal products, which can include oral contraceptives. Regulatory constraints suggest considering time-separation of administration to help ensure the therapeutic efficacy of co-administered oral medicines.


Q: Why might a doctor suggest Lax-A-Day over other common laxatives?

A: Official documents define the product's mechanism as entirely confined to the gastrointestinal tract. This action results in a non-systemic biological activity, which is a distinguishing feature compared to some other laxative types that may have systemic effects.


Q: Can Lax-A-Day be taken with anti-anxiety medications?

A: As an oral medicine, it may cause a transiently reduced absorption of co-administered oral medicines, which includes anti-anxiety medications. Regulatory constraints suggest considering time-separation of administration to help ensure the therapeutic efficacy of co-administered oral medicines.


Q: Does Lax-A-Day interact with herbal supplements?

A: Although specific warnings for every herbal supplement do not exist, the medicine's mechanism can lead to a transiently reduced absorption of anything taken orally. Consideration of time separation is generally suggested for any orally administered product, due to the risk of transiently reduced absorption.


Q: Is it safe to crush the powder or take it undissolved?

A: No, the preparation instructions strictly require the powder to be fully dissolved in liquid prior to consumption. The preparation instructions strictly require the powder to be fully dissolved prior to consumption for the medicine to leverage its osmotic mechanism correctly.

How should Lax-A-Day be stored and disposed of?

How to Store and Dispose of Lax-A-Day

The storage and disposal of Lax-A-Day (Polyethylene Glycol 3350) powder must adhere strictly to official regulatory requirements to ensure product stability and safety.

Storage Requirements

The powder must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its tightly closed original container, protected from excessive moisture and heat, and stored in a dry place. It is mandatory that the medicine be kept out of the reach of children.

Disposal Instructions

To discard unused or expired Lax-A-Day, official instructions advise patients to follow local regulations for medicine disposal. The recommended procedure is to consult a pharmacist or utilize an approved medicine take-back program to ensure the product is safely discarded and removed from the household environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lax-A-Day found in:

A-Z Index: